The PRP It is an innovative method of rejuvenating ovaries in women with reduced ovarian adequacy/function. This method uses the regenerative potential that is “hidden” in our blood cells and more specifically in platelets (the beneficial effect is mainly due to growth factors)

PRGF (Plasma Rich in Growth Factors) is an improved version of the classic PRP. The advantage of PRGF over the classic PRP concerns the very high concentration of growth factors (> 90 %) and consequently greater efficiency of the technique.

Will PRP (PRGF) work?

In properly selected incidents and when the PRP is administered in the right way to a large number of patients we observe a significant improvement. Estimation of the efficiency of the method can be done in various ways

1. Improvement of hormonal indicators (eg falling FSH, LH etc.)
2. Increase the number of follicles and/or quality of them
3. Increase the number and/or quality of the fetus produced in an IVF attempt.
4. Achieving pregnancy with physical conception.

The result of the PRP is perceived by the patient’s next cycle and lasts between 3 and 6 months in most cases.

What is the process?

The PRP process is quite simple, starting with the patient’s blood sampling and the treatment of the sample to create PRP. PRP is then injected into the patient’s ovaries under mild general anesthesia. This procedure takes about 20 minutes and is very well tolerated by patients with almost no pain or other side effects. The patient returns to her home and her daily activities the same day.

How many PRP will I need to do?

In most cases a PRP treatment is enough as it gives us a window up to 6 months to achieve pregnancy, either naturally or through IVF. In some cases, especially if there was a good response from the first treatment, we may repeat treatment in order to extend its beneficial effects.

What are the complications or contraindications

PRP is a very well tolerated treatment with little or no side effects. The most commonly observed of them include local pain or mild inflammation in the infusion area. In the vast majority of patients these symptoms are mild and are limited either automatically or by using simple painkillers.

Allergic reactions are almost never observed as the therapeutic substance is a component of the patient’s own body. Treatment is contraindicated in patients with severe blood disorders, active infections, chronic liver diseases that affect platelet function, a history of malignancy and anticoagulants or immunosuppressive drugs.

It should be emphasized here that despite the rarity of the complications, PRP treatment should be done by a specialized physician with experience in this process and after a detailed assessment of the patient.